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Objective: Patients with dementia with Lewy bodies (DLB) often experience visual
hallucinations, which are related to decreased quality of life for patients and in-
creased caregiver distress.The pathologic changes that contribute to visual hallucinations
are not known, but several hypotheses implicate deficient attentional processing.The
superior colliculus has a role in visual attention and planning eye movements and
has been directly implicated in several models of visual hallucinations.Therefore, the
present study sought to identify neurodegenerative changes that may contribute to
hallucinations in DLB. Methods: Postmortem superior colliculus tissue from 13 com-
parison, 10 DLB, and 10Alzheimer disease (AD) cases was evaluated using quantitative
neuropathologic methods. Results: α-Synuclein and tau deposition were more severe
in deeper layers of the superior colliculus. DLB cases had neuronal density reduc-
tions in the stratum griseum intermedium, an important structure in directing attention
toward visual targets. In contrast, neuronal density was reduced in all laminae of the
superior colliculus in AD. Conclusion: These findings suggest that regions involved
in directing attention toward visual targets are subject to neurodegenerative changes
in DLB. Considering several hypotheses of visual hallucinations implicating dysfunc-
tional attention toward external stimuli, these findings may provide evidence of
pathologic changes that contribute to the manifestation of visual hallucinations in
DLB. (Am J Geriatr Psychiatry 2017;■■:■■–■■)
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Dementia with Lewy bodies (DLB) is the secondmost common progressive neurodegenerative de-
mentia after Alzheimer disease (AD), accounting for
approximately 4.2% of all dementia cases.1,2 DLB is clin-
ically characterized by three core symptoms of
fluctuating cognition, parkinsonism, and complex visual
hallucinations.3 The defining histologic feature of DLB,
along with Parkinson disease and Parkinson disease
dementia, is the presence of intracytoplasmic
α-synuclein–containing inclusions termed Lewy
bodies.4 The topographic distribution of Lewy body–
related pathology in the respective disorders is believed
to underlie the patterns of clinical manifestations.5 Lewy
body pathology affects brainstem, limbic, and neocor-
tical regions in DLB,6 often in combination with the two
hallmark histologic features of AD, β-amyloid and tau
pathology.3
Visual attention is more abnormal in DLB than in
AD or Parkinson disease,7 and DLB patients show
greater impairment in filtering distracting visual stimuli
compared with AD or comparison patients.8 Deficits
in visual attention have been suggested to contribute
to the manifestation of complex visual hallucinations
in DLB.9,10 Complex visual hallucinations are common
in DLB,11 occurring in 60%–80% of cases,12 and typi-
cally consist of objects, such as animals, people, and
faces.13 Visual hallucinations are related to impaired
quality of life for DLB patients,14,15 contribute to care-
giver distress,16 and thus represent an important
therapeutic target. However, their pathologic etiolo-
gy is poorly understood.
The superior colliculus has a distinctive laminar
structure consisting of seven layers in three major gray
matter strata, the stratum griseum superficiale (SGS),
the stratum griseum intermedium (SGI) and the
stratum griseum profundum (SGP), interspersed with
predominantly fiber-rich layers.17 The superior colliculus
may be subject to neurodegenerative changes in DLB
because increased saccadic latency, which has been re-
ported in DLB,18 has also been observed in nonhuman
primates after chemical inactivation of the superior
colliculus.19 The superior colliculus is also involved in
attentional functions that are impaired in DLB, such
as target selection and the filtering of distracting
stimuli.17 One model has directly implicated dysfunc-
tion of the dorsal attentional network, with which the
superior colliculus is believed to interact, in the man-
ifestation of visual hallucinations in DLB.20 The pathway
from the retina to the inferior pulvinar, routed through
the SGS, has also been directly implicated in the man-
ifestation of hallucinations in Lewy body disease.21
The aim of the present study was to identify whether
the superior colliculus is subject to neurodegenerative
changes in DLB using stereologic measures of cell
density and densitometric analysis of neuropatho-
logic lesions. Cell density and neuropathologic data
were then compared with neuropsychological data ob-
tained during life, where available, and the known
function of the individual laminae of the superior
colliculus to determine the relationship between
neurodegenerative changes and clinical features. DLB
cases were compared with aged comparison cases and
“disease comparison” AD cases to elucidate whether
degenerative changes occur to the superior colliculus
in DLB and their relationship to its distinct clinical
manifestation.
METHODS
Tissue Preparation
Human postmortem tissue was obtained by a con-
venience sample from the Newcastle Brain Tissue
Resource, and ethical approval was granted by the
Newcastle University ethics board and the Joint Ethics
Committee of Newcastle and North Tyneside Health
Authority (reference no. 08/H0906/136). DLB andAD
subjects had been part of several prospective clinical
studies and had received detailed clinical assess-
ments according to international consensus guidelines3,22
and case note review after death. Cases with psychi-
atric or neurodegenerative comorbidities were not
included the present study. Neuropathologic assess-
ment was performed according to standardized
neuropathologic diagnostic procedures.3,23–26 Clinical and
pathologic data were collated to establish a clinico-
pathologic consensus diagnosis. Three groups of cases
were included in the present study: 10 DLB cases, 10
AD cases, and 13 clinically confirmed aged compari-
son cases that showed no, or only low, age-associated
neurodegenerative pathology at postmortem examina-
tion. Case details are presented in Table 1.
At autopsy, the upper midbrain was dissected from
the cerebrumat the level of the third cranial nerve, along
a line from the junctionof themammillarybody running
posteriorly to the upper part of the superior colliculus
(Figure 1). For stereologic analysis, 3 × 30 µm adjacent
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TABLE 1. Demographic Information
Case Identification Gender
Age at
Death (yr)
PM Interval
(hr)
Braak
NFT
McKeith
LB
Clinicopathologic
Diagnosis
NPI
(hall)
NPI Interval
to Death (mo)
C5 M 73 25 0 None Control — —
C22 F 80 25 2 None Control — —
C23 F 90 63 2 None Control — —
C24 M 91 72 1 None Control — —
C25 M 83 112 2 None Control — —
C26 M 71 25 1 None Control — —
C27 M 79 39 2 None Control — —
C28 F 93 12 3 None Control — —
C29 M 94 25 2 None Control — —
C30 F 81 75 2 None Control — —
C31 M 84 45 2 None Control — —
C32 M 78 64 2 Brainstem Control — —
C33 F 63 16 2 None Control — —
Mean ± standard deviation 81.5 ± 9 46.0 ± 29 1.8 ± 1 N/A N/A
D13 M 75 18 2 Limbic DLB — —
D24 M 77 29 2 Neocortical DLB 1 2
D6 F 78 96 3 Neocortical DLB 6 1
D25 F 91 84 5 Limbic DLB 9 5
D21 M 76 13 2 Neocortical DLB 0 2
D26 M 74 42 4 Neocortical DLB 4 9
D27 F 73 99 3 Neocortical DLB 0 27
D28 M 71 22 3 Neocortical DLB 2 10
D29 F 87 90 2 Neocortical DLB 3 —
D30 M 74 60 2 Neocortical DLB — —
Mean ± standard deviation 77.6 ± 6 55.3 ± 35 2.8 ± 1 3.1 ± 3 7.8 ± 9
A2 M 91 22 5 None AD 0 16
A9 M 68 24 6 None AD — —
A13 M 80 39 6 None AD — —
A14 M 87 21 6 None AD 0 11
A15 F 80 10 6 Amygdala AD 0 8
A16 M 82 12 6 Amygdala AD 0 —
A10 F 86 123 6 Brainstem AD — —
A17 F 58 70 6 None AD — —
A18 M 84 40 6 None AD 2 10
A19 F 89 11 6 None AD — —
Mean ± standard deviation 80.5 ± 10 37.2 ± 35 5.9 ± 0 0.4 ± 1 11.1 ± 3
Note: N/A stands for not applicable. PM interval represents the interval from death to fixation; Braak NFT represents Braak neurofibrillary pathology stage as outlined in Braak
et al.;27 McKeith LB represents Lewy body pathology stage as outlined in McKeith et al.;3 clinicopathologic diagnosis represents the consensus diagnosis made by senior clinicians
and a neuropathologist, following case note review and autopsy findings; NPI (hall) represents the score on the hallucinations subscale of the Neuropsychiatric Inventory, as de-
tailed by Cummings et al.28
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sections were cut and stained with cresyl violet. Then,
6-µmsectionswere stainedwith antibodies (KM51 anti-
α-synuclein [LeicaBiosystems,MiltonKeynes,UK], 1:250;
AT8 anti-phosphorylated tau [Autogen,Holliston,MA],
1:4,000; 4G8 anti-β-amyloid [Covance, Princeton, NJ],
1:15,000) using Menapath polymer detection kits
(Menarini Pharma, Berkshire, UK).
Stereology
Stereologic estimates of neuronal density were made
in each of the three prominent gray matter laminae of
the superior colliculus (SGS, SGI, and SGP) based on
their cytoarchitecture and laminar organization
(Figure 2).29,30 In cresyl violet sections, neurons were
differentiated from glia by the presence of Nissl sub-
stance within cytoplasm, a pale nucleus, and a single
identifiable nucleolus.31
Stereologic analysis was conducted using an
AxioVision Z.1 microscope equipped with a motor-
ized stage (Zeiss, Oberkochen, Germany), coupled to
a computer with Stereologer software (Bethesda, MA).
The rater (DE), working together with the senior in-
vestigator trained in stereologic methodology (AAK),
traced an outline around the region of interest (i.e., SGS,
SGI, or SGP) using a 2.5 × objective. Dissector frames
were placed in a uniform, random arrangement to cal-
culate the density of cells within a defined region (as
described previously).31 Neuronal counts were con-
ducted at 63 × oil-immersion objective using the optical
dissector probe. Glial cell counts were calculated in all
laminae in dissector frames of 3,500 µm2, with neuron
counts calculated in dissector frames of 1,900 µm2.
Section thickness did not vary across disease groups
in any layer. The mean coefficients of error for neu-
ronal and glial cell estimates was calculated using the
Gundersen-Jensen method.32 The mean coefficient of
error values for all stereologically obtained data showed
acceptable levels of accuracy (<0.15).33
To evaluate whether neuronal density changes occur
as a result of increasing age, postmortemdelay, or length
of timefixed in formalin, correlational analyseswere con-
ducted between these variables and neuronal density
in each layer of the superior colliculus across all cases.
To assess whether neuronal density is altered based on
the duration of disease, correlation analyses were con-
ducted between neuronal density in each layer and
duration of disease in DLB and AD cases.
Neuropathology
To quantify neuropathologic lesions, images of each
graymatter stratum of the superior colliculus (Figure 2)
were taken on a ZeissAxioVision Z.1 microscope using
a DsFi1 camera (Nikon, Tokyo, Japan). Stereologer soft-
ware was used to delineate a region of interest with a
2.5 × objective, before placement of dissector frames
in a uniform, random arrangement. This method pre-
vented the introduction of bias by giving every area
of the region of interest an equal probability of being
sampled for analysis. In all cases β-amyloid, tau, and
α-synuclein were measured using a 20 × objective. Ap-
proximately eight images were taken per lamina per
case within the dissector frames and analyzed using
ImagePro Plus v.4.1 image analysis system (Media Cy-
bernetics, Bethesda, MA). Using previously published
techniques,34 the mean percentage area of
immunopositivity was determined by standardizing
red-green-blue thresholds per antibody and apply-
ing to all sections per case. Each case thus had a mean
value generated per antibody for each stratum.
The percentage area immunoreactive for α-synuclein,
tau, and β-amyloid was compared across disease groups
FIGURE 1. Upper midbrain section stained with Loyez’s
hematoxylin. The superior colliculus is circled.
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to evaluate the vulnerability of the superior colliculus
with neurodegenerative pathology in DLB, AD, and
comparison cases. Correlational analyses were con-
ducted between neuropathologic and stereologic data
to evaluate the relationship between neuropathology
and neuronal density in each disease group.
Clinicopathologic Correlation
DLB patients had been recruited for clinical re-
search studies, during which some had received serial
assessments of visual hallucination severity and fre-
quency at frequent intervals until death.13,35 Because of
the hypothesized role of the superior colliculus in the
manifestation of visual hallucinations in Lewy body
disease,21 neuronal density and pathologic burden were
correlated with final Neuropsychiatric Inventory Hal-
lucinations Subscale score (NPI [hall]) in all layers of
the superior colliculus28 in DLB cases, where avail-
able. Final NPI (hall) scores were available for 8 of 10
DLB cases. The mean interval from final NPI assess-
ment to death was 7.81 ± 3.45 months. The relationship
between visual hallucinations and the superior
colliculus was not explored in AD because visual hal-
lucinations are not a core feature of AD and were less
frequently assessed. Additionally, as a separate disease
entity, it is possible that visual hallucinations in AD,
when present, have a different underlying pathogen-
esis to that in DLB.
Statistics
Inspection of Q-Q plots and Shapiro-Wilk tests
suggested that demographic, stereologic, and neuro-
pathologic data were either not normally distributed
or did not have homogeneity of variance. Therefore,
Kruskal-Wallis (KW) tests with post-hocMann-Whitney
U tests were used for these data. Because of the rela-
tively small sample size, corrections for multiple
comparisons were not applied. However, effect sizes
were reported using Cohen’s d. For comparisons
FIGURE 2. The delineation of the laminae of the superior
colliculus. Laminae were delineated as reported
previously.29,30 The stratum zonale (SZ) consisted
primarily of glia in the most superficial regions,
with sparse, small spindle, or triangular-shaped
neurons in regions proximal to the succeeding
layer. The SGS contained a more densely
distributed population of spindle-shaped or
triangular neurons that are slightly larger and
more deeply stained than those in the SZ. The
stratum opticum (SO) predominantly consisted
of glial cells, but some sparse triangular and
spindle-shaped neurons, similar to those of the
SGS, are also observed. The SGI contained larger,
deeply stained, multipolar neurons, which are
more frequently encountered in deeper regions
of this lamina. The stratum album intermedium
(SAI) contained some large and deep-staining
neurons reminiscent of the SGI but more
sparsely distributed and accompanied by
numerous glia and occasional small triangular
and spindle-shaped neurons. The SGP had a
densely distributed neuronal population,
predominantly consisting of medium cells with
triangular or oval shapes and no large neurons,
as observed in the previous laminae. The stratum
album profundum (SAP) was relatively acellular,
mostly consisting of fibers, although a sparse
population of neurons similar to those in the
SGP was observed. The border of the
periaqueductal gray (PAG) was noted because of
the presence of large, deeply staining neurons
on a clearly defined border.
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between different laminae, Friedman tests with post-
hoc Wilcoxon signed-ranks tests were performed.
RESULTS
Demographics
Nosignificantdifferenceswere foundbetweengroups
in age at death (KW χ2 = 2.461, df = 2, p = 0.292), post-
mortemdelay (KWχ2 = 2.708, df = 2, p = 0.258), or length
of timefixed in formalin (KWχ2 = 0.472, df = 2, p = 0.790;
Table 1).
Stereology
In the SGS there was a significant main effect of di-
agnosis on neuronal density (KW χ2 = 6.579, df = 2,
p = 0.037). No significant difference was found
between comparison cases and DLB. AD cases
(mean[ × 100] = 0.0054 [95% confidence interval {CI}:
0.0047–0.0061]) had reduced neuronal density com-
paredwith comparisoncases (mean[ × 100] = 0.0067 [95%
CI: 0.0059–0.0076];U = 27.000, p = 0.018, d = 1.014). There
wasnosignificantdifference inneuronaldensitybetween
DLB andAD in the SGS, although a trend toward a sig-
nificant reduction inAD (mean[ × 100] = 0.0054 [95%CI:
0.0047–0.0061]) compared with DLB (mean[ × 100] =
0.0062 [95%CI: 0.0053–0.0071])wasobserved (U = 26.000,
df = 1, p = 0.07, d = 0.60). Therewas no significantmain
effect of diagnosis on glial density in the SGS (Figure 3).
In the SGI there was a significant main effect of di-
agnosis on neuronal density (KW χ2 = 13.046, df = 2,
p = 0.001). DLB (mean[ × 100] = 0.0030 [95% CI: 0.0025–
0.0034]; U = 18.500, p = 0.003, d = 1.08) and AD
(mean[ × 100] = 0.0029 [95%CI: 0.0026–0.0032]; U = 13.5,
p = 0.001, d = 1.24) had reduced neuronal density com-
pared with comparison cases (mean[ × 100] = 0.0036
[95% CI: 0.0033–0.0038]). There was no significant dif-
ference in neuronal density between DLB and AD in
the SGI. There was no significant main effect of diag-
nosis on glial density in the SGI (Figure 3).
In the SGP there was a significant main effect of di-
agnosis on neuronal density (KW χ2 = 6.600, df = 2,
p = 0.037). No significant difference was found
between comparison cases and DLB. AD cases
(mean[ × 100] = 0.0028 [95% CI: 0.0025–0.0031]) had
reduced neuronal density compared with compari-
son cases (mean[ × 100] = 0.0036 [95% CI: 0.0031–
0.0040]; U = 27.000, p = 0.018, d = 1.12). There was no
significant difference in neuronal density between DLB
andAD in the SGP. There was no significant main effect
of diagnosis on glial density in the SGP (Figure 3).
FIGURE 3. Stereologic analysis of neuronal density. Neuronal and glial cell density across experimental groups in each lamina.
*p < 0.05.
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In DLB cases duration of disease was significantly
negatively correlated with neuronal density in the SGI
(rs = −0.726, N = 10, p = 0.018). However, no signifi-
cant correlations were found between duration of
disease and neuronal density in the SGS and SGP. In
AD duration of disease was not significantly corre-
lated with neuronal density in any layer.
Neuropathology
Comparisons of neuropathology between groups are
detailed in Table 2. In DLB cases there was a signifi-
cant difference in the degree of α-synuclein pathology
across the three layers (Friedman χ2 = 12.600, df = 2,
p = 0.002; Table 2). The SGI (mean = 0.0268 [95% CI:
0.0180–0.0356]; Wilcoxon z = 2.803, p = 0.005, d = 0.85)
and the SGP (mean = 0.0317 [95% CI: 0.0108–0.0525];
Wilcoxon z = 2.497, p = 0.013, d = 1.09) had a signifi-
cantly greater burden of α-synuclein pathology than
the SGS (mean = 0.0090 [95% CI: 0.0025–0.0155]). There
was no significant difference in the burden of
α-synuclein pathology between the SGI and SGP. There
were no significant correlations between α-synuclein
pathology and neuronal density across DLB, AD, and
comparison cases.
Across DLB, AD, and comparison cases, there was
a significant difference in the degree of tau patholo-
gy between the three layers (Friedman χ2 = 26.375,
p < 0.001; Table 2). The SGI (mean = 0.0929 [95% CI:
0.0074–0.1783]; Wilcoxon z = 4.330, p < 0.001, d = 0.32)
and SGP (mean = 0.1241 [95% CI: 0.0130–0.2352];
Wilcoxon z = 4.031, p < 0.001, d = 0.46) had a signifi-
cantly greater burden of tau pathology than the SGS
(mean = 0.0207 [95% CI: 0.0038–0.0376]). There was no
significant difference in the burden of tau pathology
between the SGI and SGP. Tau pathology was signifi-
cantly negatively correlated with neuronal density in
the SGI in all cases (rs = −0.404, N = 33, p = 0.022) and
the SGP (rs = −0.451, N = 33, p = 0.009). However, there
was no significant relationship between tau patholo-
gy and neuronal density in the SGS.
Across DLB, AD, and comparison cases, there was
no significant difference in β-amyloid expression across
the three layers of the superior colliculus (Table 2).
There were no significant correlations between
β-amyloid pathology and neuronal density across DLB,
AD, and comparison cases.
Clinicopathologic Correlation
There were no significant correlations between age
at death, postmortem delay or fixation time in forma-
lin, and neuronal density in any layer of the superior
colliculus. In DLB cases NPI (hall) score was signifi-
cantly positively correlated with neuronal density in
the SGS (rs = 0.874, N = 8, p = 0.005). No other
stereologic or pathologic variables were correlated with
NPI (hall) score in DLB cases.
DISCUSSION
This study demonstrates significant reductions in
neuronal density in the SGI in DLB compared with sig-
nificant neuronal loss in all laminae inAD. α-Synuclein
TABLE 2. Neuropathologic Data Demonstrating Comparisons Between Experimental Groups
Lamina Protein Target Control DLB AD
SGS α-Synuclein 0.0005 ± 0.0013 0.0090 ± 0.0091a 0.0000 ± 0.0001
Tau 0.0071 ± 0.0219 0.0153 ± 0.0230 0.0419 ± 0.0723a
β-Amyloid 0.0065 ± 0.0234 0.1315 ± 0.1514b 0.1770 ± 0.1617b
SGI α-Synuclein 0.0010 ± 0.0026 0.0268 ± 0.0123a 0.0000 ± 0.0001
Tau 0.0219 ± 0.0598 0.0421 ± 0.0684b 0.2215 ± 0.3804b
β-Amyloid 0.0315 ± 0.1062 0.1368 ± 0.1590 0.4177 ± 0.5238b
SGP α-Synuclein 0.0039 ± 0.0112 0.0317 ± 0.0292a 0.0000 ± 0.0001
Tau 0.0228 ± 0.0606 0.0491 ± 0.1014 0.3110 ± 0.4838c
β-Amyloid 0.0681 ± 0.2398 0.1260 ± 0.1385b 0.3891 ± 0.3491b
Notes: Data are the mean ratio of area of staining to total region of interest ± standard deviation.
ap <0.05 compared with control and AD.
bp <0.05 compared with control.
cp <0.05 compared with control and DLB.
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pathology was not related to neuronal density in any
layer in DLB, but tau was inversely related to neuro-
nal density in the SGI and SGP. There was no
relationship between α-synuclein pathology and hal-
lucination severity and frequency, as assessed by NPI
(hall). However, neuronal density in the SGS was pos-
itively correlated with the severity and frequency of
visual hallucinations in DLB. Distinct topographic pat-
terns of deposition were observed for α-synuclein and
tau pathology, with the SGI and SGP affected more se-
verely than the SGS.
The SGS receives retinal input36 and projects to the
medial temporal visual area (area V5/MT) through the
inferior pulvinar37,38 in a pathway believed to be in-
volved in the nonconscious perception of motion.39 In
contrast, the SGI and SGP receive inputs from wide-
ranging cortical and subcortical regions, such as motor
and association sensory cortices, the locus ceruleus, and
dorsal raphe,40 and have important roles in the selec-
tion of visual targets41 and in directing the resulting
motor output.42
Within the superior colliculus, neuropathologic
lesions occurred in a stereotypical manner, with higher
levels of α-synuclein and tau found in the SGI and SGP
compared with the SGS. This may reflect the SGI and
SGP receiving inputs from the dorsal raphe, locus
ceruleus, and pedunculopontine nucleus, which are
vulnerable to the accumulation of Lewy body and tau
pathology.43,44 In contrast, the SGS receives predomi-
nant innervation from the retina and primary visual
cortex,17 which do not appear to accumulate signifi-
cant Lewy body pathology in DLB and develop tau
pathology only at the final stage of AD pathology.27,45–47
Because tau and α-synuclein may spread throughout
the brain in a manner reminiscent of prion protein,
these distinct patterns of deposition may reflect greater
connectivity with areas that are vulnerable to early
neuropathologic lesion formation.48 However, a neu-
ropathologic study of the superior colliculus has
reported greater tau pathology in the SGI and SGP in
individuals with chronic traumatic encephalopathy, in-
dicating that these laminae may have an intrinsic
vulnerability to tau pathology.49
The present study has demonstrated that signifi-
cant neuronal loss in the superior colliculus was only
found in the SGI in DLB cases. This was in contrast
to AD, where neuronal density reductions were found
in all laminae of the superior colliculus. However, no
significant difference in neuronal density was found
between DLB and AD in the SGS and SGP. DLB had
significantly increased tau in the SGI, but not in other
layers of the superior colliculus. Because tau was neg-
atively correlated with neuronal density in the SGI and
SGP across all cases, this may indicate that tau is driving
neuronal density reductions in DLB. The greater levels
of tau pathology in AD cases may similarly cause the
reductions in neuronal density seen in all laminae of
the superior colliculus.
Previous studies in the lateral geniculate nucleus and
primary visual cortex34,46 have not demonstrated neu-
ronal loss in DLB. In contrast, neuronal loss has been
identified in the lateral pulvinar50 and in the SGI of the
superior colliculus in DLB. One model of visual hal-
lucinations has suggested that DLB patients have
difficulty engaging the dorsal attentional network to
focus attention on ambiguous stimuli, instead relying
on the self-referential default mode network.20 Because
the lateral pulvinar51 and SGI17 are implicated in visual
attention and target selection, respectively, it is tempt-
ing to speculate that neuronal losses in these regions
could impair directed attention toward visual targets.
However, visual attentional measures were not con-
ducted on the present cases, so it is not possible to
confirm whether these patients were impaired in these
faculties or whether this related to more severe visual
hallucinations. Additionally, visual hallucinations in
DLB are unlikely to result purely from neuronal loss
in the SGI and lateral pulvinar, and these changes likely
act in concert with degenerative changes elsewhere in
the visual system to elicit visual hallucinations.
Visual dysfunction, including hallucinations, in Lewy
body disease have been linked to dysfunctional path-
ways involved in blindsight, the phenomenon whereby
a blind individual may react to moving or emotional
visual stimuli.21 These pathways implicate the SGS, a
region found in the present study to be preserved in
individuals with more severe and frequent visual hal-
lucinations. This may indicate that dysfunction of this
region, or the pathway through it, is crucial for the oc-
currence of visual hallucinations. The present studywas
conducted on a relatively small sample, so it is diffi-
cult to draw strong conclusions about the relationship
between neuronal number in the SGS and visual
hallucinations.
This study was limited by the small sample size as
a result of limitations on the availability of upper mid-
brain tissue. Additionally, the superior colliculus was
sampled on three adjacent slides rather than serially
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through the entire z-axis. As a result, volume and total
neuronal number could not be estimated. This was
because of the superior colliculus being routinely dis-
sected on two different planes (coronal and axial) and
the inherent value of upper midbrain tissue. Few cases
were available that had NPI data on visual hallucina-
tions obtained during life, and this impacted the
number of cases included in the study. However, the
use of a comparator group that do not typically man-
ifest visual hallucinations suggests that the reported
findings may be related to the vulnerability of DLB pa-
tients to visual hallucinations.
In summary, the present studyhas demonstrated that
the superior colliculus is subject to neurodegenerative
changes inDLB.Specifically,neuronal losswasonly found
in the SGI in DLB. In contrast, AD cases had neuronal
loss in all layers. Because the SGI is important in di-
recting attention and aiding visual target selection, the
present results may indicate dysfunction in these func-
tions inDLB. Becausedysfunctional visual attention and
target selection have been related to visual hallucina-
tions in DLB, the present results may provide
evidence of neuropathologic changes that contribute to
the manifestation of visual hallucinations in DLB.
However, these changes are unlikely to induce visual
hallucinations on their own; thus, continued study of
the visual system is necessary to further understand the
pathologic changes that contribute to visual hallucina-
tions in DLB.
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mentia Research Programme jointly funded by Alzheimer’s
Research U.K. and Alzheimer’s Society. This study was
funded by the NHS National Institute of Health Research
Biomedical Research Unit for Lewy body dementia at New-
castle upon Tyne Hospitals NHS Foundation Trust and
Newcastle University.
Mr. Erskine was funded from the NHS National Insti-
tute for Health Research Biomedical Research Unit for Lewy
body dementia from the Yvonne Emily Mairy bequest.
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